PubMed:27248656
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-125 | Sentence | denotes | Hsp90β is involved in the development of high salt-diet-induced nephropathy via interaction with various signalling proteins. |
| T2 | 126-297 | Sentence | denotes | A high-salt diet often leads to a local intrarenal increase in renal hypoxia and oxidative stress, which are responsible for an excess production of pathogenic substances. |
| T3 | 298-501 | Sentence | denotes | Here, Wistar Kyoto/spontaneous hypertensive (WKY/SHR) rats fed a high-salt diet developed severe proteinuria, resulting from pronounced renal inflammation, fibrosis and tubular epithelial cell apoptosis. |
| T4 | 502-553 | Sentence | denotes | All these were mainly non-pressure-related effects. |
| T5 | 554-661 | Sentence | denotes | Hsp90β, TGF-β, HIF-1α, TNF-α, IL-6 and MCP-1 were shown to be highly expressed in response to salt loading. |
| T6 | 662-868 | Sentence | denotes | Next, we found that Hsp90β might play the key role in non-pressure-related effects of salt loading through a series of cellular signalling events, including the NF-κB, p38 activation and Bcl-2 inactivation. |
| T7 | 869-1027 | Sentence | denotes | Hsp90β was previously proven to regulate the upstream mediators in multiple cellular signalling cascades through stabilizing and maintaining their activities. |
| T8 | 1028-1323 | Sentence | denotes | In our study, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) or Hsp90β knockdown dramatically alleviated the high-salt-diet-induced proteinuria and renal damage without altering blood pressure significantly, when it reversed activations of NF-κB, mTOR and p38 signalling cascades. |
| T9 | 1324-1497 | Sentence | denotes | Meanwhile, Co-IP results demonstrated that Hsp90β could interact with and stabilize TAK1, AMPKα, IKKα/β, HIF-1α and Raptor, whereas Hsp90β inhibition disrupted this process. |
| T10 | 1498-1614 | Sentence | denotes | In addition, Hsp90β inhibition-mediated renal improvements also accompanied the reduction of renal oxidative stress. |
| T11 | 1615-1742 | Sentence | denotes | In conclusion, salt loading indeed exhibited non-pressure-related impacts on proteinuria and renal dysfunction in WKY/SHR rats. |
| T12 | 1743-1945 | Sentence | denotes | Hsp90β inhibition caused the destabilization of upstream mediators in various pathogenic signalling events, thereby effectively ameliorating this nephropathy owing to renal hypoxia and oxidative stress. |
| T1 | 0-125 | Sentence | denotes | Hsp90β is involved in the development of high salt-diet-induced nephropathy via interaction with various signalling proteins. |
| T2 | 126-297 | Sentence | denotes | A high-salt diet often leads to a local intrarenal increase in renal hypoxia and oxidative stress, which are responsible for an excess production of pathogenic substances. |
| T3 | 298-501 | Sentence | denotes | Here, Wistar Kyoto/spontaneous hypertensive (WKY/SHR) rats fed a high-salt diet developed severe proteinuria, resulting from pronounced renal inflammation, fibrosis and tubular epithelial cell apoptosis. |
| T4 | 502-553 | Sentence | denotes | All these were mainly non-pressure-related effects. |
| T5 | 554-661 | Sentence | denotes | Hsp90β, TGF-β, HIF-1α, TNF-α, IL-6 and MCP-1 were shown to be highly expressed in response to salt loading. |
| T6 | 662-868 | Sentence | denotes | Next, we found that Hsp90β might play the key role in non-pressure-related effects of salt loading through a series of cellular signalling events, including the NF-κB, p38 activation and Bcl-2 inactivation. |
| T7 | 869-1027 | Sentence | denotes | Hsp90β was previously proven to regulate the upstream mediators in multiple cellular signalling cascades through stabilizing and maintaining their activities. |
| T8 | 1028-1323 | Sentence | denotes | In our study, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) or Hsp90β knockdown dramatically alleviated the high-salt-diet-induced proteinuria and renal damage without altering blood pressure significantly, when it reversed activations of NF-κB, mTOR and p38 signalling cascades. |
| T9 | 1324-1497 | Sentence | denotes | Meanwhile, Co-IP results demonstrated that Hsp90β could interact with and stabilize TAK1, AMPKα, IKKα/β, HIF-1α and Raptor, whereas Hsp90β inhibition disrupted this process. |
| T10 | 1498-1614 | Sentence | denotes | In addition, Hsp90β inhibition-mediated renal improvements also accompanied the reduction of renal oxidative stress. |
| T11 | 1615-1742 | Sentence | denotes | In conclusion, salt loading indeed exhibited non-pressure-related impacts on proteinuria and renal dysfunction in WKY/SHR rats. |
| T12 | 1743-1945 | Sentence | denotes | Hsp90β inhibition caused the destabilization of upstream mediators in various pathogenic signalling events, thereby effectively ameliorating this nephropathy owing to renal hypoxia and oxidative stress. |
TEST-DiseaseOrPhenotypicFeature
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 64-75 | DiseaseOrPhenotypicFeature | denotes | nephropathy | DISEASE |
| T2 | 195-202 | DiseaseOrPhenotypicFeature | denotes | hypoxia | D000860 |
| T3 | 395-406 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T4 | 440-452 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 |
| T5 | 454-462 | DiseaseOrPhenotypicFeature | denotes | fibrosis | D005355 |
| T6 | 1175-1186 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T7 | 1191-1203 | DiseaseOrPhenotypicFeature | denotes | renal damage | DISEASE |
| T8 | 1692-1703 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T9 | 1708-1725 | DiseaseOrPhenotypicFeature | denotes | renal dysfunction | DISEASE |
| T10 | 1889-1900 | DiseaseOrPhenotypicFeature | denotes | nephropathy | DISEASE |
| T11 | 1916-1923 | DiseaseOrPhenotypicFeature | denotes | hypoxia | D000860 |
TEST-ChemicalEntity
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 593-596 | ChemicalEntity | denotes | MCP | http://purl.obolibrary.org/obo/CHEBI_50099|http://purl.obolibrary.org/obo/CHEBI_132592 |
| T3 | 1042-1093 | ChemicalEntity | denotes | 17-dimethylaminoethylamino-17-demethoxygeldanamycin | C448659|http://purl.obolibrary.org/obo/CHEBI_65324 |
| T5 | 1095-1102 | ChemicalEntity | denotes | 17-DMAG | C448659|http://purl.obolibrary.org/obo/CHEBI_65324 |
| T7 | 1440-1446 | ChemicalEntity | denotes | Raptor | http://purl.obolibrary.org/obo/CHEBI_133232 |
TEST-OrganismTaxon
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 352-356 | OrganismTaxon | denotes | rats |
| T2 | 1737-1741 | OrganismTaxon | denotes | rats |
Test-GeneOrGeneProduct
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-6 | GeneOrGeneProduct | denotes | Hsp90β |
| T2 | 105-124 | GeneOrGeneProduct | denotes | signalling proteins |
| T3 | 554-560 | GeneOrGeneProduct | denotes | Hsp90β |
| T4 | 562-567 | GeneOrGeneProduct | denotes | TGF-β |
| T5 | 569-575 | GeneOrGeneProduct | denotes | HIF-1α |
| T6 | 577-582 | GeneOrGeneProduct | denotes | TNF-α |
| T7 | 584-588 | GeneOrGeneProduct | denotes | IL-6 |
| T8 | 593-598 | GeneOrGeneProduct | denotes | MCP-1 |
| T9 | 682-688 | GeneOrGeneProduct | denotes | Hsp90β |
| T10 | 849-854 | GeneOrGeneProduct | denotes | Bcl-2 |
| T11 | 869-875 | GeneOrGeneProduct | denotes | Hsp90β |
| T12 | 1107-1113 | GeneOrGeneProduct | denotes | Hsp90β |
| T13 | 1290-1294 | GeneOrGeneProduct | denotes | mTOR |
| T14 | 1367-1373 | GeneOrGeneProduct | denotes | Hsp90β |
| T15 | 1408-1412 | GeneOrGeneProduct | denotes | TAK1 |
| T16 | 1414-1419 | GeneOrGeneProduct | denotes | AMPKα |
| T17 | 1429-1435 | GeneOrGeneProduct | denotes | HIF-1α |
| T18 | 1440-1446 | GeneOrGeneProduct | denotes | Raptor |
| T19 | 1456-1462 | GeneOrGeneProduct | denotes | Hsp90β |
| T20 | 1511-1517 | GeneOrGeneProduct | denotes | Hsp90β |
| T21 | 1743-1749 | GeneOrGeneProduct | denotes | Hsp90β |
Test-merged-2
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T5305 | 593-596 | ChemicalEntity | denotes | MCP | http://purl.obolibrary.org/obo/CHEBI_50099|http://purl.obolibrary.org/obo/CHEBI_132592 | |
| T64169 | 1042-1093 | ChemicalEntity | denotes | 17-dimethylaminoethylamino-17-demethoxygeldanamycin | C448659|http://purl.obolibrary.org/obo/CHEBI_65324 | |
| T95904 | 1095-1102 | ChemicalEntity | denotes | 17-DMAG | C448659|http://purl.obolibrary.org/obo/CHEBI_65324 | |
| T1852 | 1440-1446 | ChemicalEntity | denotes | Raptor | http://purl.obolibrary.org/obo/CHEBI_133232 | |
| T86225 | 0-6 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T85960 | 105-124 | GeneOrGeneProduct | denotes | signalling proteins | ||
| T57553 | 554-560 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T66276 | 562-567 | GeneOrGeneProduct | denotes | TGF-β | ||
| T19229 | 569-575 | GeneOrGeneProduct | denotes | HIF-1α | ||
| T69838 | 577-582 | GeneOrGeneProduct | denotes | TNF-α | ||
| T8038 | 584-588 | GeneOrGeneProduct | denotes | IL-6 | ||
| T60319 | 593-598 | GeneOrGeneProduct | denotes | MCP-1 | ||
| T51792 | 682-688 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T35801 | 849-854 | GeneOrGeneProduct | denotes | Bcl-2 | ||
| T94349 | 869-875 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T12 | 1107-1113 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T13 | 1290-1294 | GeneOrGeneProduct | denotes | mTOR | ||
| T14 | 1367-1373 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T15 | 1408-1412 | GeneOrGeneProduct | denotes | TAK1 | ||
| T16 | 1414-1419 | GeneOrGeneProduct | denotes | AMPKα | ||
| T17 | 1429-1435 | GeneOrGeneProduct | denotes | HIF-1α | ||
| T18 | 1440-1446 | GeneOrGeneProduct | denotes | Raptor | ||
| T19 | 1456-1462 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T20 | 1511-1517 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T21 | 1743-1749 | GeneOrGeneProduct | denotes | Hsp90β | ||
| T27141 | 352-356 | OrganismTaxon | denotes | rats | ||
| T83519 | 1737-1741 | OrganismTaxon | denotes | rats | ||
| T1 | 64-75 | DiseaseOrPhenotypicFeature | denotes | nephropathy | DISEASE | |
| T2 | 195-202 | DiseaseOrPhenotypicFeature | denotes | hypoxia | D000860 | |
| T3 | 395-406 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 | |
| T4 | 440-452 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 | |
| T5 | 454-462 | DiseaseOrPhenotypicFeature | denotes | fibrosis | D005355 | |
| T6 | 1175-1186 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 | |
| T7 | 1191-1203 | DiseaseOrPhenotypicFeature | denotes | renal damage | DISEASE | |
| T8 | 1692-1703 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 | |
| T9 | 1708-1725 | DiseaseOrPhenotypicFeature | denotes | renal dysfunction | DISEASE | |
| T10 | 1889-1900 | DiseaseOrPhenotypicFeature | denotes | nephropathy | DISEASE | |
| T11 | 1916-1923 | DiseaseOrPhenotypicFeature | denotes | hypoxia | D000860 |